Gene Symbol | Gene ID | Gene Info |
---|---|---|
Crem
|
ENSMUSG00000063889.10 | cAMP responsive element modulator |
Jdp2
|
ENSMUSG00000034271.9 | Jun dimerization protein 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr18_3337890_3338126 | Crem | 260 | 0.873282 | 0.40 | 2.2e-03 | Click! |
chr18_3280989_3281530 | Crem | 127 | 0.969863 | -0.35 | 7.9e-03 | Click! |
chr18_3281730_3281905 | Crem | 48 | 0.980353 | -0.31 | 2.0e-02 | Click! |
chr18_3336989_3337215 | Crem | 39 | 0.848381 | 0.27 | 4.3e-02 | Click! |
chr18_3280734_3280929 | Crem | 247 | 0.937693 | -0.27 | 4.7e-02 | Click! |
chr12_85575566_85575728 | Jdp2 | 23380 | 0.136830 | -0.71 | 1.4e-09 | Click! |
chr12_85569999_85570155 | Jdp2 | 28950 | 0.126653 | -0.65 | 5.8e-08 | Click! |
chr12_85575287_85575438 | Jdp2 | 23665 | 0.136330 | -0.61 | 7.6e-07 | Click! |
chr12_85623813_85624022 | Jdp2 | 21695 | 0.131436 | -0.59 | 2.3e-06 | Click! |
chr12_85581723_85581874 | Jdp2 | 17229 | 0.146935 | 0.58 | 3.9e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_61225302_61226760 | 111.96 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr19_61228253_61228788 | 32.18 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
91 |
0.95 |
chrX_170673967_170674476 | 21.13 |
Asmt |
acetylserotonin O-methyltransferase |
1577 |
0.54 |
chr5_32713265_32714499 | 18.79 |
Gm43852 |
predicted gene 43852 |
106 |
0.94 |
chr16_38940798_38940949 | 17.91 |
Gm22500 |
predicted gene, 22500 |
13664 |
0.21 |
chr15_84105394_84105979 | 17.46 |
Sult4a1 |
sulfotransferase family 4A, member 1 |
68 |
0.93 |
chr12_3238767_3239202 | 17.28 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
2373 |
0.24 |
chr2_180892991_180893395 | 17.03 |
Mir124a-3 |
microRNA 124a-3 |
847 |
0.31 |
chr3_17793443_17793892 | 16.65 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
253 |
0.9 |
chr7_97788183_97788962 | 16.13 |
Pak1 |
p21 (RAC1) activated kinase 1 |
31 |
0.98 |
chr2_59351695_59352106 | 15.88 |
Pkp4 |
plakophilin 4 |
9703 |
0.19 |
chr14_14347096_14348750 | 15.58 |
Gm48860 |
predicted gene, 48860 |
659 |
0.44 |
chr14_14350947_14351733 | 15.38 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr5_104109154_104109490 | 15.14 |
Gm26703 |
predicted gene, 26703 |
31 |
0.96 |
chr15_95428379_95428562 | 14.71 |
Nell2 |
NEL-like 2 |
99708 |
0.08 |
chr19_61226764_61227156 | 14.65 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
276 |
0.86 |
chr17_56475522_56476833 | 14.54 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
192 |
0.93 |
chr3_84305830_84305981 | 14.44 |
Trim2 |
tripartite motif-containing 2 |
459 |
0.87 |
chr7_79499656_79500079 | 14.31 |
Mir9-3hg |
Mir9-3 host gene |
159 |
0.9 |
chr5_109556763_109557843 | 13.94 |
Crlf2 |
cytokine receptor-like factor 2 |
830 |
0.53 |
chr18_35214941_35215148 | 13.68 |
Lrrtm2 |
leucine rich repeat transmembrane neuronal 2 |
20 |
0.56 |
chr14_63756121_63756555 | 13.23 |
Mir598 |
microRNA 598 |
29149 |
0.17 |
chr2_49619191_49619386 | 12.88 |
Kif5c |
kinesin family member 5C |
10 |
0.99 |
chr3_17592524_17592749 | 12.12 |
Gm38154 |
predicted gene, 38154 |
78052 |
0.11 |
chr2_178141291_178141933 | 11.85 |
Phactr3 |
phosphatase and actin regulator 3 |
321 |
0.92 |
chr17_45544011_45544340 | 11.76 |
Tmem151b |
transmembrane protein 151B |
5502 |
0.1 |
chr13_78099859_78100010 | 11.33 |
C130051F05Rik |
RIKEN cDNA C130051F05 gene |
12548 |
0.15 |
chr12_27083107_27083496 | 11.22 |
Gm9866 |
predicted gene 9866 |
31694 |
0.24 |
chr1_132322162_132322332 | 11.06 |
Nuak2 |
NUAK family, SNF1-like kinase, 2 |
5349 |
0.13 |
chr12_100167000_100167151 | 11.00 |
Nrde2 |
nrde-2 necessary for RNA interference, domain containing |
7422 |
0.14 |
chr11_6605194_6605847 | 10.97 |
Nacad |
NAC alpha domain containing |
533 |
0.58 |
chr9_91350886_91351318 | 10.71 |
A730094K22Rik |
RIKEN cDNA A730094K22 gene |
149 |
0.92 |
chr3_34231745_34231896 | 10.60 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
34956 |
0.16 |
chr13_65258166_65258818 | 10.25 |
Gm10775 |
predicted gene 10775 |
1047 |
0.28 |
chr1_59394147_59394298 | 10.16 |
Gm29016 |
predicted gene 29016 |
15292 |
0.18 |
chr12_3237774_3237992 | 9.90 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
1272 |
0.39 |
chr13_55471184_55472974 | 9.70 |
Mir6944 |
microRNA 6944 |
5697 |
0.08 |
chr14_24763402_24763714 | 9.65 |
Gm47906 |
predicted gene, 47906 |
70077 |
0.11 |
chr1_169485704_169485889 | 9.22 |
Gm5265 |
predicted pseudogene 5265 |
31927 |
0.17 |
chr7_109781147_109782179 | 9.19 |
Nrip3 |
nuclear receptor interacting protein 3 |
118 |
0.94 |
chr14_54772397_54772574 | 9.16 |
Slc7a8 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 |
9445 |
0.1 |
chr5_89763970_89764289 | 9.08 |
Gm25758 |
predicted gene, 25758 |
64742 |
0.13 |
chr5_35454198_35454812 | 8.98 |
Gm43377 |
predicted gene 43377 |
58407 |
0.08 |
chr1_73270841_73271081 | 8.95 |
Gm29185 |
predicted gene 29185 |
1897 |
0.38 |
chrX_143664216_143664417 | 8.81 |
Pak3 |
p21 (RAC1) activated kinase 3 |
26 |
0.99 |
chr13_68997784_68997935 | 8.72 |
Gm48593 |
predicted gene, 48593 |
160 |
0.89 |
chrX_170675926_170676102 | 8.71 |
Asmt |
acetylserotonin O-methyltransferase |
3370 |
0.36 |
chr9_14031471_14031650 | 8.63 |
1700019J19Rik |
RIKEN cDNA 1700019J19 gene |
58060 |
0.11 |
chr17_8368558_8368730 | 8.54 |
T2 |
brachyury 2 |
3752 |
0.15 |
chr3_145292206_145292951 | 8.47 |
Col24a1 |
collagen, type XXIV, alpha 1 |
51 |
0.98 |
chr9_52679712_52680046 | 8.36 |
Gm1715 |
predicted gene 1715 |
16 |
0.58 |
chr13_78181984_78182157 | 8.33 |
Gm38604 |
predicted gene, 38604 |
1089 |
0.41 |
chr13_54687539_54688580 | 8.26 |
Rnf44 |
ring finger protein 44 |
35 |
0.96 |
chr16_42444648_42444859 | 8.24 |
Gap43 |
growth associated protein 43 |
104102 |
0.07 |
chr12_92247060_92247465 | 8.08 |
Gm6841 |
predicted gene 6841 |
27885 |
0.23 |
chr11_43747463_43748363 | 7.91 |
Ttc1 |
tetratricopeptide repeat domain 1 |
69 |
0.98 |
chr6_128799495_128800104 | 7.86 |
Klrb1c |
killer cell lectin-like receptor subfamily B member 1C |
10584 |
0.1 |
chr7_84112843_84113005 | 7.75 |
Cemip |
cell migration inducing protein, hyaluronan binding |
26422 |
0.14 |
chr8_65617940_65618821 | 7.71 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
145 |
0.97 |
chr15_25758490_25758892 | 7.70 |
Myo10 |
myosin X |
74 |
0.98 |
chr12_73286641_73287386 | 7.69 |
Slc38a6 |
solute carrier family 38, member 6 |
47 |
0.81 |
chr11_84042951_84043150 | 7.67 |
Synrg |
synergin, gamma |
16395 |
0.16 |
chr14_9642748_9642899 | 7.64 |
Gm48371 |
predicted gene, 48371 |
173268 |
0.03 |
chr12_47164470_47164875 | 7.51 |
Gm36971 |
predicted gene, 36971 |
370 |
0.91 |
chr10_21144979_21145199 | 7.48 |
Gm26577 |
predicted gene, 26577 |
5 |
0.96 |
chr3_88214175_88214875 | 7.42 |
Gm3764 |
predicted gene 3764 |
30 |
0.87 |
chr14_54227036_54228159 | 7.40 |
Traj1 |
T cell receptor alpha joining 1 |
8783 |
0.08 |
chr15_12320851_12321815 | 7.36 |
Golph3 |
golgi phosphoprotein 3 |
117 |
0.87 |
chr13_100871561_100871718 | 7.31 |
Gm37830 |
predicted gene, 37830 |
1141 |
0.42 |
chr10_41072298_41072449 | 7.24 |
Gpr6 |
G protein-coupled receptor 6 |
88 |
0.96 |
chr5_150906447_150906658 | 7.24 |
Gm43298 |
predicted gene 43298 |
23910 |
0.17 |
chr14_75473074_75473492 | 7.20 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
17301 |
0.22 |
chr7_31127074_31128340 | 7.19 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr7_99795341_99796009 | 7.14 |
F730035P03Rik |
RIKEN cDNA F730035P03 gene |
14136 |
0.11 |
chr14_120477397_120478025 | 7.13 |
Rap2a |
RAS related protein 2a |
733 |
0.76 |
chr3_94484140_94484361 | 7.10 |
Celf3 |
CUGBP, Elav-like family member 3 |
77 |
0.93 |
chr16_85139441_85139618 | 7.05 |
Gm49226 |
predicted gene, 49226 |
9300 |
0.19 |
chr7_139388425_139389476 | 7.05 |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
159 |
0.97 |
chr6_6603963_6604155 | 7.05 |
Sem1 |
SEM1, 26S proteasome complex subunit |
25396 |
0.18 |
chrX_66652851_66653188 | 7.04 |
Slitrk2 |
SLIT and NTRK-like family, member 2 |
12 |
0.98 |
chr2_105668623_105668859 | 7.02 |
Pax6 |
paired box 6 |
159 |
0.93 |
chr7_4149205_4149990 | 7.01 |
Leng9 |
leukocyte receptor cluster (LRC) member 9 |
777 |
0.41 |
chr18_11883447_11884261 | 7.00 |
Gm49968 |
predicted gene, 49968 |
29277 |
0.15 |
chr19_11770210_11770497 | 6.99 |
Mrpl16 |
mitochondrial ribosomal protein L16 |
38 |
0.95 |
chr1_87170311_87170503 | 6.97 |
Prss56 |
protease, serine 56 |
12906 |
0.09 |
chr17_24689202_24689794 | 6.93 |
Syngr3 |
synaptogyrin 3 |
457 |
0.54 |
chr13_30544806_30545524 | 6.92 |
Uqcrfs1 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
197 |
0.96 |
chr3_56478690_56478916 | 6.89 |
Gm25727 |
predicted gene, 25727 |
33391 |
0.24 |
chr13_23760830_23761749 | 6.88 |
H4c1 |
H4 clustered histone 1 |
59 |
0.86 |
chr11_59163334_59163920 | 6.88 |
Iba57 |
IBA57 homolog, iron-sulfur cluster assembly |
73 |
0.95 |
chr7_79504714_79505014 | 6.86 |
Mir9-3 |
microRNA 9-3 |
400 |
0.7 |
chr17_50407363_50407533 | 6.86 |
Gm49906 |
predicted gene, 49906 |
68196 |
0.11 |
chr4_76450675_76450993 | 6.83 |
Gm42303 |
predicted gene, 42303 |
397 |
0.73 |
chr9_37177686_37177862 | 6.82 |
Gm25273 |
predicted gene, 25273 |
4780 |
0.14 |
chr8_66860040_66861058 | 6.77 |
Naf1 |
nuclear assembly factor 1 ribonucleoprotein |
332 |
0.88 |
chr18_38015233_38015405 | 6.76 |
Gm30093 |
predicted gene, 30093 |
8210 |
0.11 |
chr1_33907825_33908362 | 6.75 |
Dst |
dystonin |
132 |
0.68 |
chr12_111758304_111760062 | 6.58 |
Klc1 |
kinesin light chain 1 |
170 |
0.91 |
chr13_84571404_84571594 | 6.56 |
Gm26913 |
predicted gene, 26913 |
119442 |
0.06 |
chr17_78454364_78454515 | 6.51 |
Gm19399 |
predicted gene, 19399 |
4206 |
0.19 |
chrX_122397696_122397965 | 6.50 |
Nap1l3 |
nucleosome assembly protein 1-like 3 |
429 |
0.88 |
chr2_155276076_155277417 | 6.43 |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
143 |
0.95 |
chr2_152096969_152097193 | 6.42 |
Srxn1 |
sulfiredoxin 1 homolog (S. cerevisiae) |
8435 |
0.14 |
chr16_43464263_43464471 | 6.41 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
39247 |
0.15 |
chr19_61227192_61227555 | 6.40 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
3 |
0.96 |
chr2_94246412_94247550 | 6.33 |
Mir670hg |
MIR670 host gene (non-protein coding) |
3643 |
0.17 |
chr16_4879750_4880811 | 6.32 |
Ubald1 |
UBA-like domain containing 1 |
35 |
0.96 |
chrX_111696678_111697295 | 6.31 |
Hdx |
highly divergent homeobox |
93 |
0.98 |
chr9_87115524_87115713 | 6.25 |
Gm8282 |
predicted gene 8282 |
11716 |
0.17 |
chr15_13171596_13171768 | 6.24 |
Cdh6 |
cadherin 6 |
1993 |
0.47 |
chr17_31809967_31810118 | 6.20 |
Gm49999 |
predicted gene, 49999 |
20516 |
0.15 |
chr1_88699473_88699633 | 6.19 |
Arl4c |
ADP-ribosylation factor-like 4C |
2323 |
0.26 |
chr7_16982985_16983173 | 6.15 |
Gm42372 |
predicted gene, 42372 |
7 |
0.95 |
chr13_97775152_97775346 | 6.13 |
Rps18-ps6 |
ribosomal protein S18, pseudogene 6 |
14617 |
0.14 |
chr2_65925492_65925643 | 6.00 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
4570 |
0.25 |
chr17_9879654_9879852 | 5.99 |
Gm49808 |
predicted gene, 49808 |
15334 |
0.19 |
chr9_20726843_20728134 | 5.98 |
Olfm2 |
olfactomedin 2 |
551 |
0.72 |
chr9_55540834_55541188 | 5.97 |
Gm17226 |
predicted gene 17226 |
123 |
0.51 |
chr1_121226583_121227159 | 5.95 |
Gm29359 |
predicted gene 29359 |
2595 |
0.33 |
chr12_59219672_59220009 | 5.89 |
Fbxo33 |
F-box protein 33 |
115 |
0.95 |
chr14_14063519_14063689 | 5.86 |
Atxn7 |
ataxin 7 |
23865 |
0.16 |
chr6_17583999_17584175 | 5.85 |
Met |
met proto-oncogene |
37114 |
0.15 |
chr4_151141102_151141464 | 5.80 |
Camta1 |
calmodulin binding transcription activator 1 |
1699 |
0.42 |
chr10_92721790_92722623 | 5.80 |
Nedd1 |
neural precursor cell expressed, developmentally down-regulated gene 1 |
157 |
0.93 |
chr10_81152477_81152924 | 5.79 |
Pias4 |
protein inhibitor of activated STAT 4 |
3424 |
0.09 |
chr13_19622971_19623817 | 5.79 |
Sfrp4 |
secreted frizzled-related protein 4 |
219 |
0.92 |
chr6_73628747_73628898 | 5.78 |
Gm31747 |
predicted gene, 31747 |
20149 |
0.25 |
chr15_27923695_27923901 | 5.77 |
Trio |
triple functional domain (PTPRF interacting) |
4527 |
0.26 |
chr7_30421859_30422792 | 5.74 |
Nfkbid |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, delta |
81 |
0.91 |
chr15_64923037_64923225 | 5.73 |
Adcy8 |
adenylate cyclase 8 |
835 |
0.71 |
chr4_102759098_102759913 | 5.71 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
283 |
0.93 |
chr1_97630254_97630485 | 5.67 |
AC099860.1 |
proline rich protein BstNI subfamily 4 (PRB4), pseudogene |
30462 |
0.17 |
chr13_67813905_67814293 | 5.66 |
Zfp273 |
zinc finger protein 273 |
283 |
0.82 |
chr3_145118687_145118995 | 5.63 |
Odf2l |
outer dense fiber of sperm tails 2-like |
133 |
0.97 |
chr6_17749095_17749305 | 5.63 |
St7 |
suppression of tumorigenicity 7 |
16 |
0.81 |
chr2_49570527_49570718 | 5.62 |
Epc2 |
enhancer of polycomb homolog 2 |
41747 |
0.16 |
chr2_20944134_20944558 | 5.61 |
Arhgap21 |
Rho GTPase activating protein 21 |
927 |
0.58 |
chr5_117242256_117242407 | 5.61 |
Taok3 |
TAO kinase 3 |
1871 |
0.27 |
chr4_88868309_88868609 | 5.58 |
4930553M12Rik |
RIKEN cDNA 4930553M12 gene |
79 |
0.91 |
chr13_46006832_46006993 | 5.58 |
5033430I15Rik |
RIKEN cDNA 5033430I15 gene |
41561 |
0.14 |
chr16_29837376_29837556 | 5.52 |
Gm32679 |
predicted gene, 32679 |
2738 |
0.29 |
chr10_115587676_115588025 | 5.50 |
Lgr5 |
leucine rich repeat containing G protein coupled receptor 5 |
70 |
0.97 |
chr6_124464616_124464917 | 5.49 |
Clstn3 |
calsyntenin 3 |
28 |
0.95 |
chrX_7639834_7640277 | 5.46 |
Syp |
synaptophysin |
294 |
0.76 |
chr9_124425594_124425957 | 5.42 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
1621 |
0.32 |
chr12_102554760_102554930 | 5.40 |
Chga |
chromogranin A |
124 |
0.96 |
chr2_127521161_127522051 | 5.40 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr17_17409158_17409446 | 5.40 |
Gm26873 |
predicted gene, 26873 |
2691 |
0.21 |
chr5_5431890_5432041 | 5.38 |
Cdk14 |
cyclin-dependent kinase 14 |
11653 |
0.19 |
chr4_150651895_150652245 | 5.35 |
Slc45a1 |
solute carrier family 45, member 1 |
27 |
0.98 |
chr19_34474722_34475263 | 5.32 |
Gm26902 |
predicted gene, 26902 |
159 |
0.51 |
chr2_30929577_30930014 | 5.28 |
Ptges |
prostaglandin E synthase |
68 |
0.96 |
chr1_118435305_118435508 | 5.25 |
Clasp1 |
CLIP associating protein 1 |
15682 |
0.13 |
chr1_153661044_153661914 | 5.22 |
Rgs8 |
regulator of G-protein signaling 8 |
398 |
0.81 |
chr7_118584634_118584836 | 5.17 |
Tmc7 |
transmembrane channel-like gene family 7 |
1 |
0.97 |
chr10_42941967_42942282 | 5.17 |
Scml4 |
Scm polycomb group protein like 4 |
2243 |
0.3 |
chr4_154603637_154604075 | 5.16 |
Gm13134 |
predicted gene 13134 |
2541 |
0.22 |
chr5_107497460_107497812 | 5.13 |
Btbd8 |
BTB (POZ) domain containing 8 |
140 |
0.93 |
chr3_65958052_65958719 | 5.13 |
Ccnl1 |
cyclin L1 |
136 |
0.85 |
chr5_109552272_109552460 | 5.07 |
Gm8493 |
predicted gene 8493 |
1790 |
0.28 |
chr2_115338242_115338393 | 5.06 |
4930528P14Rik |
RIKEN cDNA 4930528P14 gene |
5963 |
0.24 |
chr7_141060848_141061734 | 5.04 |
B4galnt4 |
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
74 |
0.93 |
chr1_134361302_134362203 | 5.00 |
Tmem183a |
transmembrane protein 183A |
62 |
0.96 |
chr4_85205076_85205505 | 4.98 |
Sh3gl2 |
SH3-domain GRB2-like 2 |
151 |
0.96 |
chr15_32002923_32003126 | 4.98 |
Gm49285 |
predicted gene, 49285 |
46927 |
0.18 |
chr1_166409714_166410315 | 4.96 |
Pogk |
pogo transposable element with KRAB domain |
151 |
0.94 |
chr13_41416055_41416367 | 4.96 |
Gm48570 |
predicted gene, 48570 |
13920 |
0.15 |
chr3_62506966_62507194 | 4.94 |
Dhx36 |
DEAH (Asp-Glu-Ala-His) box polypeptide 36 |
76 |
0.98 |
chr5_110102986_110103191 | 4.92 |
Plcxd1 |
phosphatidylinositol-specific phospholipase C, X domain containing 1 |
1884 |
0.16 |
chr3_65665969_65666783 | 4.91 |
Lekr1 |
leucine, glutamate and lysine rich 1 |
59 |
0.96 |
chr2_127444443_127444898 | 4.91 |
Fahd2a |
fumarylacetoacetate hydrolase domain containing 2A |
105 |
0.96 |
chr5_104507908_104508699 | 4.89 |
Thoc2l |
THO complex subunit 2-like |
47 |
0.97 |
chr13_8995529_8996265 | 4.82 |
Gtpbp4 |
GTP binding protein 4 |
153 |
0.91 |
chr13_67360105_67360768 | 4.75 |
Gm28044 |
predicted gene, 28044 |
100 |
0.47 |
chr6_39871251_39871962 | 4.75 |
Tmem178b |
transmembrane protein 178B |
145 |
0.75 |
chr2_138406228_138406429 | 4.74 |
Btbd3 |
BTB (POZ) domain containing 3 |
127835 |
0.06 |
chr6_42692170_42692944 | 4.72 |
Tcaf1 |
TRPM8 channel-associated factor 1 |
446 |
0.72 |
chr14_67072372_67072960 | 4.71 |
Ppp2r2a |
protein phosphatase 2, regulatory subunit B, alpha |
222 |
0.92 |
chr4_56802248_56802443 | 4.70 |
Abitram |
actin binding transcription modulator |
0 |
0.49 |
chr17_53478611_53479358 | 4.69 |
Rab5a |
RAB5A, member RAS oncogene family |
250 |
0.89 |
chr10_121739461_121740067 | 4.69 |
BC048403 |
cDNA sequence BC048403 |
173 |
0.95 |
chr6_125039548_125040212 | 4.64 |
Ing4 |
inhibitor of growth family, member 4 |
19 |
0.49 |
chr7_27196124_27196735 | 4.60 |
Snrpa |
small nuclear ribonucleoprotein polypeptide A |
158 |
0.79 |
chr1_137900910_137901218 | 4.54 |
Gm4258 |
predicted gene 4258 |
2466 |
0.14 |
chr18_66458401_66458670 | 4.53 |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
2 |
0.96 |
chr10_17947650_17948709 | 4.46 |
Heca |
hdc homolog, cell cycle regulator |
112 |
0.97 |
chr6_55680988_55681310 | 4.45 |
Neurod6 |
neurogenic differentiation 6 |
114 |
0.97 |
chr2_143545715_143546271 | 4.41 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
16 |
0.67 |
chr1_193173359_193174042 | 4.39 |
A130010J15Rik |
RIKEN cDNA A130010J15 gene |
44 |
0.95 |
chr7_63444022_63445137 | 4.38 |
4930554H23Rik |
RIKEN cDNA 4930554H23 gene |
50 |
0.67 |
chr12_75307963_75308582 | 4.38 |
Rhoj |
ras homolog family member J |
50 |
0.99 |
chr8_87233823_87234288 | 4.37 |
Gm27169 |
predicted gene 27169 |
31029 |
0.16 |
chr13_99493041_99493304 | 4.36 |
5330431K02Rik |
RIKEN cDNA 5330431K02 gene |
11267 |
0.16 |
chr1_19951682_19952002 | 4.36 |
Gm37315 |
predicted gene, 37315 |
113706 |
0.07 |
chr3_129536267_129536526 | 4.33 |
Gm43072 |
predicted gene 43072 |
1745 |
0.29 |
chr18_5333845_5334616 | 4.27 |
Zfp438 |
zinc finger protein 438 |
183 |
0.95 |
chr1_132155828_132156178 | 4.26 |
Cdk18 |
cyclin-dependent kinase 18 |
16319 |
0.11 |
chr8_4325396_4325676 | 4.25 |
Elavl1 |
ELAV (embryonic lethal, abnormal vision)-like 1 (Hu antigen R) |
123 |
0.71 |
chr6_14900737_14901070 | 4.25 |
Foxp2 |
forkhead box P2 |
446 |
0.91 |
chr4_89310510_89311260 | 4.24 |
Cdkn2b |
cyclin dependent kinase inhibitor 2B |
154 |
0.95 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.0 | 126.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
5.2 | 15.6 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
4.0 | 15.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
2.9 | 8.8 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
2.0 | 6.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
2.0 | 13.9 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.9 | 5.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.8 | 5.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.7 | 5.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
1.7 | 5.1 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
1.5 | 7.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.5 | 4.5 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.4 | 4.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.4 | 5.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.2 | 3.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.2 | 6.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.2 | 3.5 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
1.1 | 3.4 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
1.1 | 8.9 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
1.1 | 3.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.1 | 7.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.1 | 3.2 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.1 | 5.3 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.1 | 5.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.0 | 1.0 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.0 | 4.2 | GO:0032202 | telomere assembly(GO:0032202) |
1.0 | 5.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
1.0 | 10.2 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
1.0 | 2.9 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
1.0 | 2.9 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.0 | 2.9 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.9 | 2.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.9 | 2.8 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.9 | 2.7 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.9 | 3.6 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.9 | 2.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.8 | 2.5 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.8 | 6.6 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.8 | 3.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.8 | 3.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.8 | 6.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.7 | 2.9 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.7 | 2.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.7 | 4.1 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.7 | 5.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.7 | 2.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.7 | 2.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.6 | 5.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.6 | 1.9 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.6 | 1.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.6 | 1.8 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.6 | 6.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.6 | 1.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.6 | 10.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.6 | 7.7 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.6 | 3.5 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.6 | 1.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 4.5 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.5 | 1.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.5 | 1.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 1.6 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.5 | 2.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 1.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 | 5.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.5 | 2.0 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.5 | 1.0 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.5 | 1.5 | GO:0030070 | insulin processing(GO:0030070) |
0.5 | 4.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.5 | 2.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.5 | 1.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.5 | 4.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.5 | 2.8 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.5 | 0.9 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.5 | 1.4 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.5 | 4.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.5 | 1.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.5 | 0.9 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 7.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.4 | 6.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.4 | 1.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 1.3 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.4 | 0.8 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.4 | 3.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 13.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.4 | 1.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.4 | 3.9 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.4 | 2.3 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.4 | 5.1 | GO:0097320 | membrane tubulation(GO:0097320) |
0.4 | 1.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.4 | 0.8 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.4 | 1.2 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.4 | 4.2 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.4 | 0.4 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.4 | 2.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.4 | 0.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.4 | 1.5 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 0.7 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.4 | 6.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 0.7 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.4 | 1.4 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.4 | 2.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.3 | 2.4 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.3 | 1.0 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.3 | 1.7 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.3 | 3.4 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.3 | 1.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 1.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 1.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 1.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.3 | 1.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.3 | 1.0 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.3 | 3.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 3.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 2.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 0.6 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.3 | 0.6 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.3 | 1.3 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 2.5 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.3 | 0.9 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 1.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.3 | 1.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 0.9 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 2.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 0.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.3 | 2.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 0.3 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.3 | 1.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 2.7 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.3 | 5.5 | GO:0007616 | long-term memory(GO:0007616) |
0.3 | 0.6 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 2.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 0.9 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.3 | 0.9 | GO:0002254 | kinin cascade(GO:0002254) |
0.3 | 0.3 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.3 | 1.4 | GO:0046618 | drug export(GO:0046618) |
0.3 | 1.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.3 | 1.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 0.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 0.5 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.3 | 0.8 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 1.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 2.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 0.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.3 | 0.3 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 3.1 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.3 | 3.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 5.1 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.3 | 0.5 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.3 | 8.8 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.3 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 2.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 4.2 | GO:0051904 | pigment granule transport(GO:0051904) |
0.2 | 3.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 3.0 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 2.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 1.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 1.7 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 0.5 | GO:0048382 | mesendoderm development(GO:0048382) |
0.2 | 2.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 0.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 1.4 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 0.5 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 3.8 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.2 | 2.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.2 | 0.9 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.2 | 1.8 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.9 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 2.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.4 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.2 | 0.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 4.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 0.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 3.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 6.0 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 0.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 1.8 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 0.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.2 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 3.6 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.2 | 1.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.2 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
0.2 | 1.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 1.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.6 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 0.2 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.2 | 3.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 1.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.2 | 0.8 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.2 | 0.6 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 2.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 0.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 0.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 5.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 9.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 1.2 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 1.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 2.6 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 0.3 | GO:0072040 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
0.2 | 1.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.9 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 1.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 1.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.2 | 2.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.8 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.2 | 0.2 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.2 | 2.2 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.2 | 6.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.3 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.2 | 5.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 0.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 2.0 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.2 | 0.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.5 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.2 | 0.5 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.6 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 1.6 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.6 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 1.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.6 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 0.4 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.1 | 1.7 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.9 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 0.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 3.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 6.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 1.0 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.1 | 0.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.3 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.1 | 1.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 1.7 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.4 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.4 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.7 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.2 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.1 | 0.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.6 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.9 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.1 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.1 | 5.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.3 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.1 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 2.0 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.1 | 0.1 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.1 | 0.7 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.8 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.2 | GO:1901631 | postsynaptic membrane assembly(GO:0097104) neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) positive regulation of presynaptic membrane organization(GO:1901631) positive regulation of synaptic vesicle clustering(GO:2000809) |
0.1 | 6.8 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.1 | 0.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 2.6 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.6 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.6 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.5 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.1 | 0.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.6 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 1.7 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 2.2 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 0.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 1.2 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.1 | 0.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 1.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.3 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 1.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 1.6 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.6 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.5 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.3 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 1.5 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.1 | 0.2 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 0.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 2.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.5 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.2 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 0.7 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.2 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 1.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.7 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 1.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 1.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 1.0 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.1 | GO:0006901 | vesicle coating(GO:0006901) |
0.1 | 3.7 | GO:0015758 | glucose transport(GO:0015758) |
0.1 | 0.1 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.1 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.1 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 1.2 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.1 | 0.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.1 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 2.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.1 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.8 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.6 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.9 | GO:0050802 | circadian sleep/wake cycle, sleep(GO:0050802) |
0.1 | 0.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 3.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 1.1 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.9 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.8 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.8 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.1 | 3.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.2 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 0.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.3 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.1 | 0.2 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.1 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.4 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.8 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 1.0 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.5 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.1 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.1 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.1 | GO:0051938 | L-glutamate import(GO:0051938) amino acid import into cell(GO:1902837) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.1 | 0.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.3 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 0.4 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 2.0 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.1 | 0.2 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.1 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.2 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.0 | 1.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.7 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.2 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.0 | GO:0031050 | dsRNA fragmentation(GO:0031050) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.0 | 0.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.4 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.0 | 0.4 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 1.2 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.0 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.0 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.8 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 7.4 | GO:0008202 | steroid metabolic process(GO:0008202) |
0.0 | 0.1 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.3 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.0 | 0.3 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.5 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.0 | 0.1 | GO:0071864 | regulation of cell proliferation in bone marrow(GO:0071863) positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.0 | 0.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.1 | GO:0042938 | dipeptide transport(GO:0042938) |
0.0 | 0.2 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.0 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.5 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.4 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.0 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 3.0 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.2 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 2.1 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.0 | 0.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.1 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.0 | 0.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.0 | 0.3 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.0 | 4.3 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.1 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 3.4 | GO:0043523 | regulation of neuron apoptotic process(GO:0043523) |
0.0 | 0.0 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.3 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.0 | 0.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.8 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.0 | 0.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.0 | 2.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.2 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.0 | 0.4 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.0 | 0.0 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.0 | 0.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.0 | 0.0 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.0 | 0.5 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.0 | 0.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.2 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.0 | 0.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.0 | 0.3 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 | 0.1 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.0 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
0.0 | 0.1 | GO:0002711 | positive regulation of T cell mediated immunity(GO:0002711) |
0.0 | 0.1 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.0 | 0.1 | GO:0060931 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.0 | 0.1 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.1 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.5 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 1.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.0 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.5 | GO:0001825 | blastocyst formation(GO:0001825) |
0.0 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 0.1 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 | 0.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.0 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.0 | 0.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.0 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.0 | 0.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.0 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.1 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.0 | 0.0 | GO:1901382 | trophectodermal cell proliferation(GO:0001834) chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.0 | 0.0 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.5 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 1.7 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.0 | 0.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.0 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.0 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.0 | 0.0 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 0.0 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.0 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.0 | 0.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.0 | 0.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.0 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.1 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.1 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.0 | 0.1 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.7 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.0 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.0 | 0.0 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.0 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 0.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 0.1 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.0 | GO:0046015 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) regulation of transcription by glucose(GO:0046015) positive regulation of transcription by glucose(GO:0046016) |
0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.1 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.0 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.1 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.0 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.0 | 0.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.0 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 0.0 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.0 | 0.0 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.0 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.1 | GO:0032648 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
0.0 | 0.1 | GO:0002931 | response to ischemia(GO:0002931) |
0.0 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.0 | 0.1 | GO:0097531 | mast cell migration(GO:0097531) |
0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.1 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.0 | 0.0 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0019740 | nitrogen utilization(GO:0019740) ammonium transmembrane transport(GO:0072488) |
0.0 | 0.2 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.0 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 0.0 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.0 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.0 | 0.0 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.0 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.0 | 0.4 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.0 | 0.0 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.0 | 0.0 | GO:0072505 | divalent inorganic anion homeostasis(GO:0072505) |
0.0 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.0 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.0 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.1 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.0 | 0.0 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.0 | 0.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.0 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.0 | 0.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.3 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.0 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.0 | 0.1 | GO:0003016 | respiratory system process(GO:0003016) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 22.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
2.0 | 16.3 | GO:0071437 | invadopodium(GO:0071437) |
1.4 | 4.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
1.3 | 8.1 | GO:0005915 | zonula adherens(GO:0005915) |
1.3 | 5.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.3 | 5.3 | GO:0042583 | chromaffin granule(GO:0042583) |
1.3 | 3.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.1 | 3.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.8 | 6.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.8 | 0.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.7 | 2.8 | GO:0098536 | deuterosome(GO:0098536) |
0.7 | 2.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 2.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.6 | 1.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.6 | 5.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.6 | 4.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.6 | 4.1 | GO:0070187 | telosome(GO:0070187) |
0.5 | 2.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 2.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.5 | 2.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.5 | 2.8 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 1.8 | GO:0030689 | Noc complex(GO:0030689) |
0.4 | 4.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 2.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 4.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 3.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 3.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 1.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 4.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 1.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.4 | 1.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 2.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.4 | 5.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 4.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 3.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 6.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 0.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 1.9 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.3 | 0.9 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 1.8 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.3 | 1.4 | GO:0033503 | HULC complex(GO:0033503) |
0.3 | 4.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.3 | 2.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 4.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 3.9 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 2.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 6.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 2.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 5.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.7 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 0.4 | GO:0044393 | microspike(GO:0044393) |
0.2 | 6.1 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 9.4 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 0.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 1.2 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 2.1 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 1.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 4.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 2.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 4.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 4.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 3.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 6.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 1.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 1.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 5.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 0.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.4 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 0.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 1.0 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 1.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 4.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 2.3 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 3.9 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 1.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 4.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 1.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 5.1 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 19.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 6.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 4.8 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 2.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.6 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 2.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 2.2 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 1.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.2 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.8 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 3.3 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 4.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.6 | GO:0071010 | prespliceosome(GO:0071010) |
0.1 | 1.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 2.3 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 1.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 5.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.8 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 2.2 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.1 | 1.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 0.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 1.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 1.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 2.1 | GO:0016605 | PML body(GO:0016605) |
0.0 | 2.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.3 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 2.6 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 1.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 4.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.6 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.4 | GO:0098803 | respiratory chain complex(GO:0098803) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 3.4 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 1.0 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.0 | 7.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 2.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 136.6 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 2.0 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 1.3 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.0 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.0 | 2.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.6 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 0.0 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.0 | 0.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.0 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.5 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.1 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.0 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.1 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 0.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 15.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.7 | 5.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.6 | 6.5 | GO:0042731 | PH domain binding(GO:0042731) |
1.4 | 11.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.3 | 4.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.3 | 110.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
1.3 | 1.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
1.3 | 3.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.2 | 3.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.2 | 8.4 | GO:0003680 | AT DNA binding(GO:0003680) |
1.1 | 6.6 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.0 | 5.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
1.0 | 4.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.0 | 2.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.0 | 7.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.9 | 0.9 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.9 | 3.4 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.9 | 2.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.7 | 2.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.7 | 3.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.7 | 2.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.7 | 2.7 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.7 | 3.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.7 | 7.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 3.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.6 | 1.9 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 3.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.6 | 1.9 | GO:2001070 | starch binding(GO:2001070) |
0.6 | 3.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.6 | 2.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.6 | 9.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.6 | 2.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.5 | 2.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 1.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.5 | 5.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.5 | 1.6 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.5 | 2.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 6.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.5 | 1.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 5.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 0.9 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.5 | 1.9 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.5 | 1.8 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.4 | 4.0 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.4 | 8.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.4 | 19.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.4 | 7.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 5.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 3.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 3.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.4 | 1.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 1.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.4 | 3.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 4.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 5.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 1.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 2.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 0.7 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.4 | 1.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 1.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 8.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.3 | 1.3 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 1.6 | GO:0070061 | fructose binding(GO:0070061) |
0.3 | 1.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 2.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 1.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.3 | 2.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 2.6 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.3 | 6.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 1.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 1.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 2.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 1.5 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.3 | 5.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 0.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 2.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 0.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 0.9 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 4.8 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.3 | 1.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 3.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 0.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 0.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 15.8 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 3.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 1.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 0.8 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 1.8 | GO:0042300 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.3 | 1.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 2.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 0.8 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.3 | 11.7 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 2.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 0.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 1.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 1.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 1.8 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.2 | 0.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 7.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 5.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 3.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 3.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 17.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 0.8 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.2 | 3.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 17.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 1.2 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 1.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 2.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 1.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 4.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 1.2 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 3.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 1.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 1.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 2.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 1.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.2 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.2 | 7.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.5 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.6 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 5.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 2.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 4.0 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 0.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 3.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 2.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.8 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 2.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 6.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 2.9 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.5 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.9 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.5 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.1 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 3.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 1.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 3.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 2.4 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 1.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.7 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.8 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 2.5 | GO:0043906 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.1 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 12.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 0.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 1.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 2.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 1.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 1.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 1.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.1 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 1.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 3.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 1.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 1.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 1.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 2.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 5.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.0 | 0.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 1.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.2 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 2.5 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.2 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 1.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 1.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 6.8 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.0 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 1.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.4 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 2.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 1.6 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.0 | 0.2 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 1.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.0 | 0.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.0 | 3.0 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.8 | GO:0016247 | channel regulator activity(GO:0016247) |
0.0 | 0.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 2.7 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 1.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.0 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.0 | GO:0030984 | kininogen binding(GO:0030984) |
0.0 | 0.7 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 1.2 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 1.0 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 1.7 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 1.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 1.4 | GO:0016747 | transferase activity, transferring acyl groups other than amino-acyl groups(GO:0016747) |
0.0 | 0.0 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 124.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.8 | 22.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 1.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.4 | 11.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 8.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 4.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 4.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 3.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 1.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 8.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 3.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 0.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 2.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 1.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 2.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 1.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 3.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 2.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 7.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 6.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 2.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 4.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 4.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 2.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 2.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 4.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 2.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 3.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.9 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 1.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 113.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.5 | 15.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.5 | 16.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.7 | 8.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.6 | 1.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.5 | 5.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.5 | 5.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.5 | 4.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 0.8 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.4 | 8.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 4.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 6.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 2.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 3.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 3.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 1.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 8.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 5.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 3.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 6.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 1.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 2.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 1.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 2.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 11.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 1.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 1.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 3.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.2 | 1.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 2.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 4.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 1.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 2.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 2.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 6.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 1.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 1.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 2.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.3 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 3.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 2.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 0.9 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 1.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.8 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 4.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.8 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.0 | 1.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 1.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.6 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 1.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 1.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 1.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 2.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 1.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 2.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |